Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
70.88
-0.42 (-0.59%)
Official Closing Price
Updated: 6:30 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Edwards Lifesciences
Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
August 21, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
July 24, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Reports Second Quarter Results
July 24, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
July 17, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Watch for Continued Gains in Shares of Edwards Lifesciences Corporation (EW)
December 17, 2021
Via
Investor Brand Network
Edwards Lifesciences to Acquire Innovalve
July 15, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
June 05, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Sell Critical Care to BD
June 03, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Reports First Quarter Results
April 25, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
April 18, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
The 5 Stocks Most Sold By Insiders This Year
April 16, 2024
Insiders are selling these 5 stocks increased as their markets advanced, and gains may be capped. Long-term outlooks are positive for growth and share prices.
Via
MarketBeat
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
April 07, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
March 11, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
February 23, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Can financial, healthcare, energy stocks rise as rates stay high?
February 08, 2024
Sectors including financials, healthcare, utilities and energy outperform as interest rates remain high, but some of those industries face challenges in 2024.
Via
MarketBeat
Edwards Lifesciences Reports Fourth Quarter Results
February 06, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
February 02, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024
January 30, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
From
Edwards Lifesciences Corporation
Via
Business Wire
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
December 07, 2023
From
Edwards Lifesciences Corporation
Via
Business Wire
Patients With Deadly Heart Disease Underdiagnosed, Including 66% of Women: AI-Powered Clinical Study Shows
September 08, 2023
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Analysts Say GE's Healthcare Spinoff Has $20 Upside
September 05, 2023
General Electric’s spinoff, GE HealthCare Technologies Inc., is delivering some impressive results and has growth opportunities well worth tuning in to.
Via
MarketBeat
S&P 500 Component DexCom Set For Further Price, Earnings Growth
November 13, 2022
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Edwards Life Sciences Stock Disaster Could Be Your Bounty
November 07, 2022
Heart disease equipment maker Edwards Life Sciences (NYSE: EW) stock has fallen (-46%) on the year after a disastrous reaction to its Q3 2022 earnings report.
Via
MarketBeat
Topics
Death
Exposures
COVID-19
Death
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand
October 04, 2022
Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary – The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the...
Via
FinancialNewsMedia
Topics
Death
Economy
Exposures
Death
Economy
Edwards Lifesciences Corp. (EW) Looks to Continue to Trade Above its Annual-High Share Price Today
December 22, 2021
Via
Investor Brand Network
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.